Combined Retrospective-Prospective Cohort Study to Know the Risk of Sensorineural Hearing Loss in Patients of Drug Resistant TB Receiving Anti Tuberculous Treatment (ATT) at Tertiary Care Centre in South Gujarat

• Published in: Indian journal of otolaryngology, and head, and neck surgery and head, and neck surgery, 2023-12, Vol.75 (4), p.3185-3190
• Main Authors: Bhavsar, Khushi N., Chaudhari, Anandkumar V., Chauhan, Jahanvika M., Patel, Rahulkumar B., Contractor, Jaymin A., Shamaliya, Khyati D., Desai, Pururava J., Roy, Prachi P., Patel, Hiteshri C.
• Format: Article
• Language: English
• Subjects: Drug therapy; Head and Neck Surgery; Hearing loss; Medicine; Medicine & Public Health; Original; Original Article; Otorhinolaryngology; Tuberculosis
• ISSN: 2231-3796; 0973-7707
• DOI: 10.1007/s12070-023-03702-8

Combined retrospective—prospective cohort study was done to know the risk of sensorineural hearing loss in patients of drug resistant Tuberculosis (TB) receiving Anti Tuberculous Treatment (ATT) at tertiary care centre in South Gujarat. Study was done by using retrospective and prospective data of the patients of drug resistant TB of NCHS who received injectable ATT and referred by department of Respiratory Medicine to ENT department for purpose of hearing evaluation pre and post treatment (Case cohort). Age and sex matched control cohort was also used which includes patients of non-drug resistant TB who were not receiving Injectable ATT. Incidence of SNHL in patients taking ATT for drug resistant tuberculosis in our study was 33.9%. The Relative Risk of SNHL was 14.3%. The Attributable Risk of SNHL (preventable SNHL) was 93%.